M. Fenton Dennis's most recent trade in AnaptysBio Inc was a trade of 3,015 Common Stock done at an average price of $24.0 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Dennis M. Fenton | Director | Sale of securities on an exchange or to another person at price $ 23.97 per share. | 18 Jun 2025 | 3,015 | 4,965 (0%) | 0% | 24.0 | 72,270 | Common Stock |
| AnaptysBio Inc | Dennis M. Fenton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 6,030 | 7,980 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 6,030 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 21 Jun 2024 | 1,950 | 1,950 (0%) | 0% | 23.2 | 45,182 | Common Stock |
| AnaptysBio Inc | Dennis M. Fenton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,900 | 3,900 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,900 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis Fenton M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | M. Fenton Dennis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) |